{"id":"https://openalex.org/W4313197804","doi":"https://doi.org/10.1016/j.phrs.2022.106631","title":"Role of monomeric amyloid-\u03b2 in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies","display_name":"Role of monomeric amyloid-\u03b2 in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies","alternate_titles":[],"publication_year":2022,"publication_date":"2022-12-28","ids":{"openalex":"https://openalex.org/W4313197804","doi":"https://doi.org/10.1016/j.phrs.2022.106631","pmid":"https://pubmed.ncbi.nlm.nih.gov/36586644"},"language":"en","primary_location":{"id":"doi:10.1016/j.phrs.2022.106631","doi":"https://doi.org/10.1016/j.phrs.2022.106631","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.phrs.2022.106631","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1043661822005771/pdf","source":{"id":"https://openalex.org/S54485712","display_name":"Pharmacological Research","issn_l":"1043-6618","issn":["1043-6618","1096-1186"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","oarl","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4313197804"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S1043661822005771/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075804608","display_name":"Bruno Pietro Imbimbo","orcid":"https://orcid.org/0000-0002-0327-7262","observed_orcids":["https://orcid.org/0000-0002-0327-7262"]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"}],"raw_author_name":"Bruno P. Imbimbo","raw_affiliation_strings":["Department of Research & Development, Chiesi Farmaceutici, Parma, Italy. Electronic address: b.imbimbo@chiesi.com","Department of Research & Development, Chiesi Farmaceutici, Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Research & Development, Chiesi Farmaceutici, Parma, Italy. Electronic address: b.imbimbo@chiesi.com","institution_ids":["https://openalex.org/I4210162628"]},{"raw_affiliation_string":"Department of Research & Development, Chiesi Farmaceutici, Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090604564","display_name":"Stefania Ippati","orcid":"https://orcid.org/0000-0001-8408-6216","observed_orcids":["https://orcid.org/0000-0001-8408-6216"]},"institutions":[{"id":"https://openalex.org/I4210133214","display_name":"IRCCS Ospedale San Raffaele","ror":"https://ror.org/039zxt351","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210133214","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"}],"raw_author_name":"Stefania Ippati","raw_affiliation_strings":["San Raffaele Scientific Institute, San Raffaele Hospital, 20132 Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Raffaele Scientific Institute, San Raffaele Hospital, 20132 Milan, Italy","institution_ids":["https://openalex.org/I4210133214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001163013","display_name":"Mark Watling","orcid":"https://orcid.org/0000-0001-6855-6222","observed_orcids":["https://orcid.org/0000-0001-6855-6222"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Mark Watling","raw_affiliation_strings":["CNS & Pain Department, TranScrip Ltd, Reading, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNS & Pain Department, TranScrip Ltd, Reading, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047087896","display_name":"Camillo Imbimbo","orcid":"https://orcid.org/0000-0001-7747-806X","observed_orcids":["https://orcid.org/0000-0001-7747-806X"]},"institutions":[{"id":"https://openalex.org/I25217355","display_name":"University of Pavia","ror":"https://ror.org/00s6t1f81","country_code":"IT","type":"education","lineage":["https://openalex.org/I25217355"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"}],"raw_author_name":"Camillo Imbimbo","raw_affiliation_strings":["Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy","institution_ids":["https://openalex.org/I25217355"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5075804608"],"corresponding_institution_ids":["https://openalex.org/I4210162628"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":{"value":3500,"currency":"USD","value_usd":3500},"fwci":1.7433,"has_fulltext":true,"cited_by_count":76,"citation_normalized_percentile":{"value":0.873706,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"187","issue":null,"first_page":"106631","last_page":"106631"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9200000166893005},{"id":"https://openalex.org/keywords/soluble-amyloid-beta","display_name":"soluble amyloid-beta","score":0.7549999952316284},{"id":"https://openalex.org/keywords/amyloid-beta-protofibrils","display_name":"amyloid-beta protofibrils","score":0.7310000061988831},{"id":"https://openalex.org/keywords/amyloid-plaques","display_name":"amyloid plaques","score":0.7609999775886536},{"id":"https://openalex.org/keywords/secretase-inhibitors","display_name":"secretase inhibitors","score":0.7739999890327454},{"id":"https://openalex.org/keywords/beta-secretase-inhibitors","display_name":"beta-secretase inhibitors","score":0.8240000009536743},{"id":"https://openalex.org/keywords/gamma-secretase-inhibitors","display_name":"gamma-secretase inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/aducanumab","display_name":"aducanumab","score":0.8709999918937683},{"id":"https://openalex.org/keywords/lecanemab","display_name":"lecanemab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/donanemab","display_name":"donanemab","score":1.0},{"id":"https://openalex.org/keywords/anti-amyloid-monoclonal-antibodies","display_name":"anti-amyloid monoclonal antibodies","score":0.953000009059906},{"id":"https://openalex.org/keywords/cerebrospinal-fluid-amyloid-beta","display_name":"cerebrospinal fluid amyloid-beta","score":0.9649999737739563},{"id":"https://openalex.org/keywords/cognitive-decline","display_name":"cognitive decline","score":0.828000009059906},{"id":"https://openalex.org/keywords/amyloid-beta-aggregation","display_name":"amyloid-beta aggregation","score":0.5820000171661377},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.3490000069141388}],"concepts":[{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.5845627784729004},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5683199167251587},{"id":"https://openalex.org/C2984863031","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Cognitive decline","level":4,"score":0.5599993467330933},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.5477948188781738},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4942000210285187},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.47384291887283325},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4447312653064728},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.444121390581131},{"id":"https://openalex.org/C2779651940","wikidata":"https://www.wikidata.org/wiki/Q54196","display_name":"Cerebrospinal fluid","level":2,"score":0.4245340824127197},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3987466096878052},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3406321108341217},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2689114212989807},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26446688175201416},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.23875486850738525},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.22576212882995605},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.13065475225448608}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053829","descriptor_name":"Amyloid Precursor Protein Secretases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.phrs.2022.106631","doi":"https://doi.org/10.1016/j.phrs.2022.106631","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.phrs.2022.106631","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1043661822005771/pdf","source":{"id":"https://openalex.org/S54485712","display_name":"Pharmacological Research","issn_l":"1043-6618","issn":["1043-6618","1096-1186"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","oarl","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Research","raw_type":"journal-article"},{"id":"pmid:36586644","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36586644","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.phrs.2022.106631","doi":"https://doi.org/10.1016/j.phrs.2022.106631","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.phrs.2022.106631","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1043661822005771/pdf","source":{"id":"https://openalex.org/S54485712","display_name":"Pharmacological Research","issn_l":"1043-6618","issn":["1043-6618","1096-1186"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","oarl","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4313197804.pdf","grobid_xml":"https://content.openalex.org/works/W4313197804.grobid-xml"},"referenced_works_count":88,"referenced_works":["https://openalex.org/W139300322","https://openalex.org/W152311838","https://openalex.org/W1149434589","https://openalex.org/W1494074009","https://openalex.org/W1527636392","https://openalex.org/W1870790543","https://openalex.org/W1964117773","https://openalex.org/W1978317025","https://openalex.org/W1986777598","https://openalex.org/W1991988242","https://openalex.org/W2000879436","https://openalex.org/W2007350172","https://openalex.org/W2014704142","https://openalex.org/W2015484447","https://openalex.org/W2033987011","https://openalex.org/W2039716280","https://openalex.org/W2051489981","https://openalex.org/W2053116497","https://openalex.org/W2066792703","https://openalex.org/W2072360118","https://openalex.org/W2088129757","https://openalex.org/W2096063777","https://openalex.org/W2096947785","https://openalex.org/W2099693452","https://openalex.org/W2105631420","https://openalex.org/W2113518834","https://openalex.org/W2118935254","https://openalex.org/W2134711807","https://openalex.org/W2135771073","https://openalex.org/W2139225271","https://openalex.org/W2166416515","https://openalex.org/W2168357345","https://openalex.org/W2174862691","https://openalex.org/W2298179978","https://openalex.org/W2439340751","https://openalex.org/W2494586080","https://openalex.org/W2511469658","https://openalex.org/W2559272093","https://openalex.org/W2584909754","https://openalex.org/W2626001339","https://openalex.org/W2626414736","https://openalex.org/W2734651019","https://openalex.org/W2735226312","https://openalex.org/W2763403209","https://openalex.org/W2772872651","https://openalex.org/W2773346142","https://openalex.org/W2787612390","https://openalex.org/W2802659348","https://openalex.org/W2802918776","https://openalex.org/W2888433054","https://openalex.org/W2900308507","https://openalex.org/W2907547898","https://openalex.org/W2909242954","https://openalex.org/W2937097483","https://openalex.org/W2964512741","https://openalex.org/W2964825595","https://openalex.org/W2969258607","https://openalex.org/W2982501787","https://openalex.org/W3006119534","https://openalex.org/W3040932876","https://openalex.org/W3045897262","https://openalex.org/W3107979799","https://openalex.org/W3137826907","https://openalex.org/W3152692563","https://openalex.org/W3173004646","https://openalex.org/W3174935792","https://openalex.org/W3176983361","https://openalex.org/W3200817894","https://openalex.org/W3208392943","https://openalex.org/W4200169681","https://openalex.org/W4206046172","https://openalex.org/W4213065543","https://openalex.org/W4213077593","https://openalex.org/W4220762599","https://openalex.org/W4221136944","https://openalex.org/W4225741213","https://openalex.org/W4281616414","https://openalex.org/W4281627323","https://openalex.org/W4296286739","https://openalex.org/W4296328734","https://openalex.org/W4296546783","https://openalex.org/W4306663551","https://openalex.org/W4306842911","https://openalex.org/W4308942327","https://openalex.org/W4310461604","https://openalex.org/W4310776178","https://openalex.org/W4365787461","https://openalex.org/W4367041078"],"related_works":["https://openalex.org/W4205122449","https://openalex.org/W4402433600","https://openalex.org/W2135737549","https://openalex.org/W1971166622","https://openalex.org/W4388414385","https://openalex.org/W4413105951","https://openalex.org/W2051324813","https://openalex.org/W3146410983","https://openalex.org/W2511203602","https://openalex.org/W7166701191"],"abstract_inverted_index":{"According":[0],"to":[1,19,40,78,194],"the":[2,14,63,111,180],"\u03b2-amyloid":[3],"(A\u03b2)":[4],"hypothesis":[5],"of":[6,32,113,173,189],"Alzheimer's":[7],"disease":[8],"(AD),":[9],"brain":[10,80,197],"A\u03b2":[11,33,120,142,150,165,168,175,192,198],"accumulation":[12],"is":[13],"primary":[15],"cascade":[16],"event":[17],"leading":[18],"cognitive":[20,56,95,125,136,157],"deficit":[21],"and":[22,51,57,89,96,107,109,131,200],"dementia.":[23],"Numerous":[24],"anti-A\u03b2":[25,68],"drugs":[26,115],"either":[27],"inhibiting":[28],"production":[29],"or":[30,34,153],"aggregation":[31],"stimulating":[35],"its":[36,76],"clearance":[37],"have":[38,91],"failed":[39],"show":[41],"clinical":[42,58,97],"benefit":[43],"in":[44,159,183],"large":[45],"scale":[46],"AD":[47,73,101,161,184],"trials,":[48],"with":[49,124],"\u03b2-":[50],"\u03b3-secretase":[52,132],"inhibitors":[53,133],"consistently":[54],"worsening":[55],"decline.":[59],"In":[60],"June":[61],"2021,":[62],"FDA":[64],"approved":[65],"aducanumab,":[66],"an":[67],"monoclonal":[69,147],"antibody":[70],"for":[71],"early":[72,160],"based":[74],"on":[75,116],"ability":[77],"reduce":[79],"amyloid":[81],"plaques,":[82],"while":[83],"two":[84],"other":[85],"amyloid-clearing":[86],"antibodies":[87,148],"(lecanemab":[88],"donanemab)":[90],"recently":[92],"produced":[93],"encouraging":[94],"results.":[98],"We":[99,127,144],"reviewed":[100],"trials":[102],"using":[103],"PubMed,":[104],"meeting":[105],"abstracts":[106],"ClinicalTrials.gov":[108],"evaluated":[110],"effects":[112,137],"such":[114],"cerebrospinal":[117],"fluid":[118],"(CSF)":[119],"levels,":[121],"correlating":[122],"them":[123],"effects.":[126],"found":[128],"that":[129,146,179],"\u03b2-secretase":[130],"produce":[134],"detrimental":[135],"by":[138,162],"significantly":[139],"reducing":[140],"CSF":[141],"levels.":[143],"speculate":[145],"targeting":[149],"protofibrils,":[151],"fibrils":[152],"plaques":[154],"may":[155,185],"improve":[156],"performance":[158],"increasing":[163],"soluble":[164,190],"levels":[166,188],"through":[167],"aggregate":[169],"disassembly":[170],"and/or":[171],"stabilization":[172],"existing":[174],"monomers.These":[176],"findings":[177],"suggest":[178],"real":[181],"culprit":[182],"be":[186],"decreased":[187],"monomeric":[191],"due":[193],"sequestration":[195],"into":[196],"aggregates":[199],"plaques.":[201]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4313197804","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":24},{"year":2024,"cited_by_count":21},{"year":2023,"cited_by_count":19}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2023-01-06T00:00:00"}
